Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 4, Pages 983-990
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.1080/21645515.2015.1012004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter
- (2014) Cécile van Els et al. Human Vaccines & Immunotherapeutics
- An Inactivated, Adjuvanted Whole Virion Clade 2.2 H5N1 (A/Chicken/Astana/6/05) Influenza Vaccine Is Safe and Immunogenic in a Single Dose in Humans
- (2013) Abylay R. Sansyzbay et al. Clinical and Vaccine Immunology
- Immunological assessment of influenza vaccines and immune correlates of protection
- (2013) Adrian Reber et al. Expert Review of Vaccines
- Virus-induced humoral immunity: on how B cell responses are initiated
- (2013) Franziska Zabel et al. Current Opinion in Virology
- Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity
- (2012) Natalija Budimir et al. PLoS One
- A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses
- (2011) Jiri Beran et al. CLINICAL THERAPEUTICS
- An international technology platform for influenza vaccines
- (2011) Jan Hendriks et al. VACCINE
- Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
- (2011) Timo Vesikari et al. VACCINE
- Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling
- (2011) Felix Geeraedts et al. PLoS Pathogens
- Immunogenicity, Safety, and Cross‐Reactivity of an Inactivated, Adjuvanted, Prototype Pandemic Influenza (H5N1) Vaccine: A Phase II, Double‐Blind, Randomized Trial
- (2009) Jiang Wu et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children
- (2009) Terry Nolan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine
- (2009) John H. Beigel et al. JOURNAL OF INFECTIOUS DISEASES
- Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
- (2009) Eric Plennevaux et al. LANCET
- Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection
- (2009) Daisuke Ikeno et al. MICROBIOLOGY AND IMMUNOLOGY
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
- (2009) Tristan W. Clark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
- (2008) Felix Geeraedts et al. Influenza and Other Respiratory Viruses
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- The Developing Countries Vaccine Manufacturers’ Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries
- (2008) Suresh Jadhav et al. VACCINE
- Immunogenetics of seasonal influenza vaccine response
- (2008) Gregory A. Poland et al. VACCINE
- Efficacy and effectiveness of influenza vaccination
- (2008) Kristin L. Nichol VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search